Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Related structures:
AlphaFold database: A4HLN3
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 117 | 119 | PF00675 | 0.538 |
CLV_PCSK_KEX2_1 | 117 | 119 | PF00082 | 0.538 |
CLV_PCSK_KEX2_1 | 40 | 42 | PF00082 | 0.680 |
CLV_PCSK_PC1ET2_1 | 40 | 42 | PF00082 | 0.680 |
CLV_PCSK_PC7_1 | 36 | 42 | PF00082 | 0.669 |
CLV_PCSK_SKI1_1 | 192 | 196 | PF00082 | 0.378 |
CLV_PCSK_SKI1_1 | 23 | 27 | PF00082 | 0.695 |
CLV_PCSK_SKI1_1 | 5 | 9 | PF00082 | 0.684 |
CLV_PCSK_SKI1_1 | 73 | 77 | PF00082 | 0.489 |
DEG_APCC_DBOX_1 | 27 | 35 | PF00400 | 0.648 |
DEG_APCC_DBOX_1 | 72 | 80 | PF00400 | 0.488 |
DOC_CYCLIN_yCln2_LP_2 | 89 | 95 | PF00134 | 0.541 |
DOC_MAPK_gen_1 | 192 | 200 | PF00069 | 0.320 |
DOC_MAPK_MEF2A_6 | 323 | 332 | PF00069 | 0.315 |
DOC_PP1_RVXF_1 | 206 | 213 | PF00149 | 0.462 |
DOC_PP2B_LxvP_1 | 89 | 92 | PF13499 | 0.549 |
DOC_PP4_FxxP_1 | 95 | 98 | PF00568 | 0.581 |
DOC_USP7_MATH_1 | 129 | 133 | PF00917 | 0.741 |
DOC_USP7_MATH_1 | 158 | 162 | PF00917 | 0.549 |
DOC_USP7_MATH_1 | 369 | 373 | PF00917 | 0.455 |
DOC_USP7_MATH_2 | 63 | 69 | PF00917 | 0.744 |
DOC_WW_Pin1_4 | 133 | 138 | PF00397 | 0.746 |
LIG_Actin_WH2_2 | 283 | 301 | PF00022 | 0.455 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.706 |
LIG_BRCT_BRCA1_1 | 176 | 180 | PF00533 | 0.536 |
LIG_FHA_1 | 285 | 291 | PF00498 | 0.328 |
LIG_FHA_1 | 394 | 400 | PF00498 | 0.641 |
LIG_FHA_2 | 142 | 148 | PF00498 | 0.671 |
LIG_GBD_Chelix_1 | 115 | 123 | PF00786 | 0.572 |
LIG_LIR_Apic_2 | 99 | 104 | PF02991 | 0.637 |
LIG_LIR_Gen_1 | 256 | 265 | PF02991 | 0.447 |
LIG_LIR_Gen_1 | 335 | 342 | PF02991 | 0.328 |
LIG_LIR_Gen_1 | 61 | 69 | PF02991 | 0.587 |
LIG_LIR_Nem_3 | 256 | 260 | PF02991 | 0.440 |
LIG_LIR_Nem_3 | 335 | 340 | PF02991 | 0.328 |
LIG_LIR_Nem_3 | 61 | 67 | PF02991 | 0.601 |
LIG_NBox_RRM_1 | 194 | 204 | PF00076 | 0.538 |
LIG_NRBOX | 327 | 333 | PF00104 | 0.449 |
LIG_SH2_CRK | 101 | 105 | PF00017 | 0.705 |
LIG_SH2_CRK | 15 | 19 | PF00017 | 0.596 |
LIG_SH2_CRK | 257 | 261 | PF00017 | 0.435 |
LIG_SH2_CRK | 337 | 341 | PF00017 | 0.344 |
LIG_SH2_GRB2like | 47 | 50 | PF00017 | 0.769 |
LIG_SH2_NCK_1 | 15 | 19 | PF00017 | 0.701 |
LIG_SH2_SRC | 47 | 50 | PF00017 | 0.769 |
LIG_SH2_STAP1 | 244 | 248 | PF00017 | 0.434 |
LIG_SH3_3 | 57 | 63 | PF00018 | 0.634 |
LIG_SUMO_SIM_anti_2 | 72 | 78 | PF11976 | 0.725 |
LIG_SUMO_SIM_par_1 | 329 | 335 | PF11976 | 0.328 |
LIG_SUMO_SIM_par_1 | 72 | 78 | PF11976 | 0.739 |
LIG_TRAF2_1 | 105 | 108 | PF00917 | 0.628 |
LIG_TRAF2_1 | 97 | 100 | PF00917 | 0.632 |
LIG_TYR_ITIM | 255 | 260 | PF00017 | 0.405 |
MOD_CK1_1 | 324 | 330 | PF00069 | 0.413 |
MOD_CK1_1 | 398 | 404 | PF00069 | 0.635 |
MOD_CK2_1 | 141 | 147 | PF00069 | 0.684 |
MOD_Cter_Amidation | 164 | 167 | PF01082 | 0.473 |
MOD_GlcNHglycan | 127 | 130 | PF01048 | 0.483 |
MOD_GlcNHglycan | 176 | 179 | PF01048 | 0.442 |
MOD_GlcNHglycan | 322 | 326 | PF01048 | 0.347 |
MOD_GlcNHglycan | 43 | 46 | PF01048 | 0.628 |
MOD_GlcNHglycan | 79 | 82 | PF01048 | 0.619 |
MOD_GlcNHglycan | 86 | 89 | PF01048 | 0.490 |
MOD_GSK3_1 | 125 | 132 | PF00069 | 0.687 |
MOD_GSK3_1 | 17 | 24 | PF00069 | 0.636 |
MOD_GSK3_1 | 280 | 287 | PF00069 | 0.437 |
MOD_N-GLC_1 | 48 | 53 | PF02516 | 0.739 |
MOD_NEK2_1 | 157 | 162 | PF00069 | 0.490 |
MOD_NEK2_1 | 174 | 179 | PF00069 | 0.386 |
MOD_NEK2_1 | 240 | 245 | PF00069 | 0.523 |
MOD_NEK2_1 | 253 | 258 | PF00069 | 0.324 |
MOD_NEK2_1 | 284 | 289 | PF00069 | 0.407 |
MOD_NEK2_1 | 393 | 398 | PF00069 | 0.616 |
MOD_NEK2_1 | 6 | 11 | PF00069 | 0.672 |
MOD_NEK2_1 | 75 | 80 | PF00069 | 0.714 |
MOD_NEK2_2 | 158 | 163 | PF00069 | 0.564 |
MOD_NEK2_2 | 294 | 299 | PF00069 | 0.449 |
MOD_PIKK_1 | 401 | 407 | PF00454 | 0.652 |
MOD_PIKK_1 | 48 | 54 | PF00454 | 0.760 |
MOD_PK_1 | 395 | 401 | PF00069 | 0.673 |
MOD_PKA_2 | 277 | 283 | PF00069 | 0.560 |
MOD_PKA_2 | 369 | 375 | PF00069 | 0.426 |
MOD_PKA_2 | 382 | 388 | PF00069 | 0.438 |
MOD_Plk_1 | 141 | 147 | PF00069 | 0.599 |
MOD_Plk_1 | 280 | 286 | PF00069 | 0.441 |
MOD_Plk_4 | 21 | 27 | PF00069 | 0.654 |
MOD_Plk_4 | 227 | 233 | PF00069 | 0.432 |
MOD_Plk_4 | 280 | 286 | PF00069 | 0.437 |
MOD_Plk_4 | 335 | 341 | PF00069 | 0.328 |
MOD_Plk_4 | 382 | 388 | PF00069 | 0.600 |
MOD_Plk_4 | 398 | 404 | PF00069 | 0.433 |
MOD_ProDKin_1 | 133 | 139 | PF00069 | 0.745 |
MOD_SUMO_rev_2 | 20 | 25 | PF00179 | 0.741 |
MOD_SUMO_rev_2 | 225 | 230 | PF00179 | 0.308 |
TRG_DiLeu_BaEn_1 | 335 | 340 | PF01217 | 0.344 |
TRG_ENDOCYTIC_2 | 15 | 18 | PF00928 | 0.594 |
TRG_ENDOCYTIC_2 | 184 | 187 | PF00928 | 0.564 |
TRG_ENDOCYTIC_2 | 257 | 260 | PF00928 | 0.413 |
TRG_ENDOCYTIC_2 | 337 | 340 | PF00928 | 0.328 |
TRG_ER_diArg_1 | 117 | 119 | PF00400 | 0.538 |
TRG_NLS_MonoExtN_4 | 163 | 170 | PF00514 | 0.334 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P843 | Leptomonas seymouri | 79% | 100% |
A0A0S4JIY4 | Bodo saltans | 46% | 85% |
A0A1X0P137 | Trypanosomatidae | 55% | 94% |
A0A3Q8IDU0 | Leishmania donovani | 91% | 100% |
A0A422MV93 | Trypanosoma rangeli | 55% | 88% |
A4I968 | Leishmania infantum | 91% | 100% |
C9ZIW4 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 55% | 87% |
E9B409 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 90% | 100% |
Q4Q415 | Leishmania major | 89% | 100% |
V5BLY0 | Trypanosoma cruzi | 54% | 93% |